Slides: Current Best Practice and Emerging Strategies for Pulmonary Arterial Hypertension

Learn expert perspectives on identifying and managing PAH, including earlier and accurate diagnosis, treatment approaches, and the impact of disease progression.
Vallerie V. McLaughlin, MD
Ioana R. Preston, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 974 KB
Released: March 25, 2021

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Related Content

James C. Coons, PharmD, FCCP, BCCP; Martha Kingman, DNP, FNP-C; and Vallerie McLaughlin, MD, answer questions from a ProCE webinar on considerations in PAH

James C. Coons, PharmD, FCCP, BCCP Martha Kingman, DNP, FNP-C Vallerie V. McLaughlin, MD Released: March 30, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue